Mitotech is a biotechnology company that specializes in developing a range of innovative mitochondria-targeted small molecules. Their portfolio of products is designed to address the role of dysfunctional mitochondria in various age-related and debilitating conditions, including neurodegenerative, metabolic, and cardiovascular diseases. Mitochondria play a crucial role in essential biological processes such as mitophagy, oxidative stress, apoptosis, and ferroptosis, which directly impact the overall wellbeing of living cells.

The company's core team consists of a diverse group of experts, including scientific researchers, clinical drug development professionals, and experienced business leaders. By combining their business skills, industry expertise, and in-depth scientific knowledge, Mitotech aims to tackle complex scientific challenges, such as protecting mitochondria against oxidative stress and combating uncontrolled inflammation. Their ultimate goal is to transform their innovative research into successful pharmaceutical products.

With a breakthrough in delivering highly active compounds into mitochondria, Mitotech seeks to provide effective medicines based on this novel mechanism of action to patients worldwide. Their mission is to leverage their expertise to address a wide spectrum of neurodegenerative and metabolic conditions, improving the lives of individuals globally. © 2023 Mitotech, SA - All Rights Reserved - Privacy Policy